Ticagrelor for PCI Post Thrombolysis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Ticagrelor is a first line therapy along with aspirin for patients undergoing primary PCI for STEMI. However, many patients are still treated with fibrinolytic therapy and the safety and efficacy of Ticagrelor has not been investigated in this patients population. The present study is proposed to study the safety and efficacy of Ticagrelor in patients undergoing PCI post fibrinolytic therapy for STEMI.
Epistemonikos ID: 7585dce6755deadfec0aeeb702289c66d8e7d067
First added on: May 11, 2024